# Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

> **NCT00127088** · PHASE2 · SUSPENDED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 37 (—)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **PROCEDURE:** laparoscopic radical prostatectomy

## Key facts

- **NCT ID:** NCT00127088
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 37 (—)
- **Last updated:** 2006-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127088, "Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00127088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*